Cargando…

Identification of six hub genes in mantle cell lymphoma patients with BTKi resistance

BACKGROUND: Bruton tyrosine kinase inhibitor (BTKi) resistance is an unsolved problem in the treatment of relapse/recurrence (R/R) mantle cell lymphoma (MCL). Although salvage therapy following ibrutinib resistance has been attempted in recent years, the survival of resistant patients was significan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Shuozi, Yang, Ping, Wang, Lingli, Li, Chunyuan, Zhang, Weilong, Wang, Jing, Jing, Hongmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652540/ https://www.ncbi.nlm.nih.gov/pubmed/36388812 http://dx.doi.org/10.21037/atm-22-4314

Ejemplares similares

Exosome complex genes mediate RNA degradation and predict survival in mantle cell lymphoma
por: Zhang, Weilong, et al.
Publicado: (2019)

Identification of key gene modules and hub genes of human mantle cell lymphoma by coexpression network analysis
por: Guo, Dongmei, et al.
Publicado: (2020)

p53 directly downregulates the expression of CDC20 to exert anti-tumor activity in mantle cell lymphoma
por: Chen, Yingtong, et al.
Publicado: (2023)

Dysregulation of N(6)-methyladenosine regulators predicts poor patient survival in mantle cell lymphoma
por: Zhang, Weilong, et al.
Publicado: (2019)

P1110: REAL-WORLD TREATMENT PATTERNS OF BRUTON TYROSINE KINASE INHIBITORS (BTKI) IN PATIENTS WITH MANTLE CELL LYMPHOMA (MCL) IN COMMUNITY ONCOLOGY PRACTICES IN THE UNITED STATES (US)
por: Shah, Bijal, et al.
Publicado: (2023)

P1112: PATIENT-REPORTED OUTCOMES (PRO) AMONG PATIENTS WITH MANTLE CELL LYMPHOMA RECEIVING PIRTOBRUTINIB AFTER PRIOR COVALENT BTKI: INTERIM PRO ANALYSIS FROM THE BRUIN PHASE 1/2 STUDY
por: Cohen, Jonathon, et al.
Publicado: (2023)

Harnessing the Effects of BTKi on T Cells for Effective Immunotherapy against CLL
por: Mhibik, Maissa, et al.
Publicado: (2019)

Identification of Hub Genes and Key Pathways Associated with Follicular Lymphoma
por: Zhang, Qing, et al.
Publicado: (2022)

Identification and characterization of the cellular subclones that contribute to the pathogenesis of mantle cell lymphoma
por: Tang, Junling, et al.
Publicado: (2018)

Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients With Lymphoproliferative Disorders on BTKi
por: Zamprogna, Giulia, et al.
Publicado: (2023)

Management of Drug Resistance in Mantle Cell Lymphoma
por: Roué, Gaël, et al.
Publicado: (2020)

Transcriptional programming drives Ibrutinib-resistance evolution in mantle cell lymphoma
por: Zhao, Xiaohong, et al.
Publicado: (2021)

Identification of immune-related genes and development of a prognostic model in mantle cell lymphoma
por: Zhang, Wei, et al.
Publicado: (2022)

Single-cell RNA-seq reveals the immune escape and drug resistance mechanisms of mantle cell lymphoma
por: Wang, Liang, et al.
Publicado: (2020)

Hypertension and incident cardiovascular events after next-generation BTKi therapy initiation
por: Chen, Sunnia T., et al.
Publicado: (2022)

Identification of Methylated Genes Associated with Aggressive Clinicopathological Features in Mantle Cell Lymphoma
por: Enjuanes, Anna, et al.
Publicado: (2011)

Smoldering mantle cell lymphoma
por: Ye, Haige, et al.
Publicado: (2017)

Targeting glutaminase is therapeutically effective in ibrutinib-resistant mantle cell lymphoma
por: Li, Lingzhi, et al.
Publicado: (2022)

Booster and Btki Interruption Improve Response to Sars-Cov-2 Vaccine in Patients with CLL
por: Bryer, Emily, et al.
Publicado: (2022)

Hub genes and their key effects on prognosis of Burkitt lymphoma
por: Xu, Yan-Feng, et al.
Publicado: (2023)

Gene mutations and actionable genetic lesions in mantle cell lymphoma
por: Ahmed, Makhdum, et al.
Publicado: (2016)

Identification of four novel hub genes as monitoring biomarkers for colorectal cancer
por: Luo, Danqing, et al.
Publicado: (2022)

The clinical features, therapeutic responses, and prognosis of the patients with mantle cell lymphoma
por: Ying, Zhi-Tao, et al.
Publicado: (2012)

Educational Case: Mantle Cell Lymphoma
por: Mai, Brenda, et al.
Publicado: (2020)

Exploration and identification of six novel ferroptosis-related hub genes as potential gene signatures for peripheral nerve injury
por: Zhang, Yifei, et al.
Publicado: (2023)

Case report: Composite mantle cell lymphoma and classical Hodgkin lymphoma
por: Wang, Hongyu, et al.
Publicado: (2023)

Identification of six hub genes and analysis of their correlation with drug sensitivity in acute myeloid leukemia through bioinformatics
por: Cai, Daxia, et al.
Publicado: (2021)

Is a BTKi or BCL2i preferable for first “novel” therapy in CLL? The case for BTKis
por: Brem, Elizabeth A., et al.
Publicado: (2022)

Immune response to COVID‐19 vaccination in patients with Waldenström macroglobulinaemia who pause their BTKi therapy
por: Rankin, Katherine, et al.
Publicado: (2023)

Mantle cell lymphoma with endobronchial involvement: A case report
por: Ding, Yi-Zong, et al.
Publicado: (2022)

P592: SINGLE-CELL RNA SEQUENCING REVEALS THE SPATIAL HETEROGENEITY OF EXHAUSTED T CELLS IN BTKI-RESISTANT RICHTER TRANSFORMATION PATIENTS
por: Sha, Yeqin, et al.
Publicado: (2023)

Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma
por: Zhao, Xiaohong, et al.
Publicado: (2017)

Identification of immune hub genes participating in the pathogenesis and progression of Vogt-Koyanagi-Harada disease
por: Wang, Yiqi, et al.
Publicado: (2022)

Identification of several hub-genes associated with periodontitis using integrated microarray analysis
por: GUO, XINXING, et al.
Publicado: (2015)

Mantle cell lymphoma with features of marginal-zone lymphoma
por: Randen, Ulla, et al.
Publicado: (2011)

Primary gastric mantle cell lymphoma
por: Petranovic, Duska, et al.
Publicado: (2012)

Mantle cell lymphoma with skin involvement
por: Kalińska-Bienias, Agnieszka, et al.
Publicado: (2015)

Esophageal location of mantle cell lymphoma
por: Michopoulos, Spyros
Publicado: (2016)

Tracheobronchial involvement of mantle cell lymphoma
por: Tong, Lin, et al.
Publicado: (2018)

Mantle Cell Lymphoma Case Report
por: Podzolkov, V.I., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_iqoq3mkpuunljlvbobkre4gshh